In a report published Tuesday, Morgan Stanley analyst Andrew Schenker reiterated an Equal-Weight rating on Molina Healthcare MOH.
In the report, Morgan Stanley noted, “MOH reported EPS of ($0.20), which compared to our ($0.18). As expected, the quarter was negatively impacted by a retroactive rate reduction in Washington, worth ~$15M pre-tax in 4Q. Adjusted for Washington, reported MLR of 88.7% was below our 89.6% forecast, but G&A of 11.0% exceeded our 10.4% estimate. Investments ahead of reform (~$45M to $50M in 4Q) likely drove this metric higher in the quarter.”
Molina Healthcare closed on Monday at $35.84.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in